儿童造血干细胞移植后心包积液研究进展.

Pericardial effusion is a potentially life-threatening complication after hematopoietic stem cell transplantation (HSCT) in children. The incidence of pericardial effusion in children was 4.4% to 37.8%.The occurrence of pericardial effusion is related to many risk factors such as transplant-related thrombomicroangiopathy, pretreatment drugs, graft-versus-host disease, graft type, immunosuppressant, infection and so on. The treatment of pericardial effusion lacks a unified protocol, mainly focus onsupportive treatment, etiologic treatment and pericardial puncture. his paper reviewed the risk factors and treatment of pericardial effusion after HSCT in recent years, and provided suggestions for improving the early identification, diagnosis and treatment of pericardial effusion after HSCT in children. [ABSTRACT FROM AUTHOR]